TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.70
+0.03 (0.39%)
Feb 11, 2026, 2:22 PM CST
Market Cap616.94M -3.5%
Revenue (ttm)n/a
Net Income-25.36M
EPS-0.32
Shares Out80.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume133,873
Average Volume197,677
Open7.67
Previous Close7.67
Day's Range7.47 - 7.84
52-Week Range6.99 - 10.60
Beta-1.55
RSI43.25
Earnings DateMar 24, 2026

About TaiwanJ Pharmaceuticals

TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. Th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 13
Stock Exchange Taipei Exchange
Ticker Symbol 6549
Full Company Profile

Financial Performance

Financial Statements